Pages that link to "Q37187692"
Jump to navigation
Jump to search
The following pages link to Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base (Q37187692):
Displaying 8 items.
- Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies (Q38658279) (← links)
- RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer. (Q42799162) (← links)
- An Abraded Surface of Doxorubicin-Loaded Surfactant-Containing Drug Delivery Systems Effectively Reduces the Survival of Carcinoma Cells (Q50865516) (← links)
- Combination of doxorubicin with harmine-loaded liposomes exerting synergistic antitumor efficacy. (Q52742986) (← links)
- Xanthine scaffold: scope and potential in drug development (Q57298107) (← links)
- Doxorubicin-loaded quaternary ammonium palmitoyl glycol chitosan polymeric nanoformulation: uptake by cells and organs (Q60301115) (← links)
- Thiophene Derivatives as Anticancer Agents and Their Delivery to Tumor Cells Using Albumin Nanoparticles (Q61450909) (← links)
- Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach (Q89801078) (← links)